Mangoceuticals, Common Stock Stock Short Ratio
| MGRX Stock | 2.37 0.14 5.58% |
Mangoceuticals, Common Stock fundamentals help investors to digest information that contributes to Mangoceuticals, Common's financial success or failures. It also enables traders to predict the movement of Mangoceuticals, Stock. The fundamental analysis module provides a way to measure Mangoceuticals, Common's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mangoceuticals, Common stock.
Mangoceuticals, |
Mangoceuticals, Common Stock Company Short Ratio Analysis
Mangoceuticals, Common's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Mangoceuticals, Common Short Ratio | 0.44 X |
Most of Mangoceuticals, Common's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mangoceuticals, Common Stock is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Mangoceuticals, Short Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Mangoceuticals, Common is extremely important. It helps to project a fair market value of Mangoceuticals, Stock properly, considering its historical fundamentals such as Short Ratio. Since Mangoceuticals, Common's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Mangoceuticals, Common's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Mangoceuticals, Common's interrelated accounts and indicators.
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Mangoceuticals, Common Stock has a Short Ratio of 0.44 times. This is 88.72% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The short ratio for all United States stocks is 89.0% higher than that of the company.
Mangoceuticals, Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mangoceuticals, Common's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mangoceuticals, Common could also be used in its relative valuation, which is a method of valuing Mangoceuticals, Common by comparing valuation metrics of similar companies.Mangoceuticals, Common is currently under evaluation in short ratio category among its peers.
Mangoceuticals, Common ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Mangoceuticals, Common's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Mangoceuticals, Common's managers, analysts, and investors.Environmental | Governance | Social |
Mangoceuticals, Fundamentals
| Return On Equity | -1.08 | ||||
| Return On Asset | -0.58 | ||||
| Operating Margin | (13.05) % | ||||
| Current Valuation | 5.63 M | ||||
| Shares Outstanding | 2.4 M | ||||
| Shares Owned By Insiders | 36.19 % | ||||
| Shares Owned By Institutions | 1.92 % | ||||
| Number Of Shares Shorted | 101.62 K | ||||
| Price To Book | 0.42 X | ||||
| Price To Sales | 6.95 X | ||||
| Revenue | 731.49 K | ||||
| Gross Profit | 4.85 K | ||||
| EBITDA | (9.19 M) | ||||
| Net Income | (9.21 M) | ||||
| Total Debt | 128.68 K | ||||
| Book Value Per Share | 7.12 X | ||||
| Cash Flow From Operations | (7 M) | ||||
| Short Ratio | 0.44 X | ||||
| Earnings Per Share | (6.45) X | ||||
| Market Capitalization | 6.02 M | ||||
| Total Asset | 1.05 M | ||||
| Retained Earnings | (11.23 M) | ||||
| Working Capital | 607.38 K | ||||
| Net Asset | 1.05 M |
About Mangoceuticals, Common Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mangoceuticals, Common Stock's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mangoceuticals, Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mangoceuticals, Common Stock based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| V | Visa Class A | |
| MSFT | Microsoft |
Additional Tools for Mangoceuticals, Stock Analysis
When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.